Investors need to invest their money somewhere, I think stock in the telehealth and respiratory disease companies is what the market will look at along with the usual save haven gold. RAP uniquely offers both solutions with CE and TGA approval for the last 5 months and 10 months of FDA review and question......I'm actually very surprise the pps hasn't recover back to 25c. I think the wearable device company sold their payment in shares below 20c and some SI sold hoping to pick up some "cheap" blue chips stocks....well look what happen to those blue chips today. If there is the global recession, best to invest in health care companies and especially company that focus on respiratory disease after the global attention on COVID-19.
Ann: Trading Halt, page-158
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #